MetaCap

ClearPoint Neuro (CLPT) vs Utah Medical Products (UTMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Utah Medical Products (UTMD) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 26.0% versus a loss of 50.0%. Over five years, UTMD leads with a -42.3% price change compared with -50.0% for CLPT. ClearPoint Neuro is the larger company by market cap ($221.5 million vs $198.0 million), about 1.1 times the size.

Utah Medical Products pays a dividend yielding 1.78%, while ClearPoint Neuro does not currently pay one. Utah Medical Products converts more of its revenue into profit, with a net margin of 29.3% versus -69.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLPT-50.00%UTMD+25.98%
+45%-5%-55%
Nov 21, 20251 yearNov 20, 2026
CLPT-51.78%UTMD-39.90%
+99%+11%-77%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLPT versus UTMD key metrics
MetricCLPTUTMD
Share price$6.91$69.49
Market cap$221.49M$198.01M
1-day change-5.47%-2.07%
YTD return-49.49%+24.18%
1-year return-50.00%+25.98%
5-year return-50.04%-42.25%
P/E ratio (TTM)—20.81
EPS (TTM)$-1.21$3.34
Dividend yield0.00%1.78%
Annual dividend$0.00$1.24
Revenue (latest FY)$36.97M$38.52M
Revenue growth (YoY)+17.78%-5.83%
Net income (latest FY)$-25.54M$11.29M
Gross margin61.38%57.12%
Operating margin-65.36%29.60%
Net margin-69.08%29.30%
52-week high$19.63$76.89
52-week low$6.85$53.80
Distance from 52-week high-64.80%-9.62%
Analyst consensusnone—
Avg. price target upside+211.14%—
Average volume701.64K33.70K
Shares outstanding32.05M2.85M
Employees172140
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • UTMD has outperformed CLPT by 76.0 percentage points over the past year.
  • Utah Medical Products offers a meaningfully higher dividend yield (1.78% vs 0.00%).
  • Utah Medical Products is more profitable, keeping 29.3 cents of every revenue dollar as net income versus -69.1 cents for ClearPoint Neuro.
  • ClearPoint Neuro grew revenue faster in its latest fiscal year (+17.78% vs -5.83%).

About ClearPoint Neuro

CLPT stock →

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.

Health Care · Medical/Dental Instruments · 172 employees

About Utah Medical Products

UTMD stock →

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.

Health Care · Medical/Dental Instruments · 140 employees

CLPT vs UTMD FAQ

Which is bigger, ClearPoint Neuro or Utah Medical Products?

ClearPoint Neuro (CLPT) is larger, with a market capitalization of $221.49M compared with $198.01M for Utah Medical Products (UTMD).

Which stock has performed better over the past year, CLPT or UTMD?

UTMD returned +25.98% over the past 12 months, compared with -50.00% for CLPT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, ClearPoint Neuro or Utah Medical Products?

Utah Medical Products pays a dividend yielding 1.78%, while ClearPoint Neuro does not currently pay a regular dividend.

Are ClearPoint Neuro and Utah Medical Products in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons